Regulatory Pathways for Anti-Aging Therapies Remain Unclear Despite Growing Interest
As of mid-2026, neither the U.S. Food and Drug Administration nor the European Medicines Agency officially recognizes aging as a medical indication for drug approval, leaving developers of…